Arecor Therapeutics plc (AREC) ORD GBP0.01

- Add to watchlist
- Create an alert
- This stock can be held in a




38.00p
40.00p
170.00p
£14.35 million
38.00p
40.00p
35.40p
n/a
0.00p (0.00%) Previous:
0.00p
2
n/a
1,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2024 | 31/12/2023 |
---|---|---|
Revenue (£m) | 5.05 | 4.57 |
Profit before tax (£m) | (10.62) | (8.90) |
Adjusted EPS (p): | (0.31) | (0.28) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Arecor enters collaboration with unnamed global pharma major
26 March 2025 14:51
-
Revenue higher, cash reserves fall at Arecor
3 February 2025 14:40
-
Arecor to wind up operations at Tetris Pharma subsidiary
10 January 2025 14:59
-
Arecor to present on Investor Meet Company
24 April 2025 07:00
-
Grant of Options and PDMR Dealing
23 April 2025 07:00
-
Final results for 2024
22 April 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.